The association between the variant allele (Lys) and better lymph node status appear to corroborate the notion of reduced signaling with the variant EGFR isoform [13], leading to lower invasiveness, which reinforce the role of EGFR in breast cancer pathogenesis. This evidence concerns the gene EGFR and breast cancer.